These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 5929064)

  • 41. Diurnal patterns of 17-hydroxy-corticosteroid excretion in psychiatric illness.
    Ellman GL; Blacker KH
    Dis Nerv Syst; 1969 Oct; 30(10):683-8. PubMed ID: 5355300
    [No Abstract]   [Full Text] [Related]  

  • 42. Urinary catecholamine excretion by healthy children. I. Daily excretion of dopamine, norepinephrine, epinephrine, and 3-methoxy-4-hydroxymandelic acid.
    Voorhess ML
    Pediatrics; 1967 Feb; 39(2):252-7. PubMed ID: 6017961
    [No Abstract]   [Full Text] [Related]  

  • 43. [A metabolite of catecholamines, vanil-mandelic acid (V.M.A.) in gestosis of third trimester of pregnancy].
    Stringa L; Guglielminetti G; Bianchini A
    Quad Clin Ostet Ginecol; 1965 Dec; 20(12):783-91. PubMed ID: 5895787
    [No Abstract]   [Full Text] [Related]  

  • 44. [The behavior of urinary elimination of catecholamines in headache caused by arterial hypertension].
    Cavallazzi G; Massara G
    Arch Ital Otol Rinol Laringol Patol Cervicofacc; 1968; 79(5):636-43. PubMed ID: 4387754
    [No Abstract]   [Full Text] [Related]  

  • 45. Rhythmometry on urinary 17-ketosteroid excretion by healthy men and women and patients with chronic schizophrenia; possible chronopathology in depressive illness.
    Halberg F; Vestergaard P; Sakai M
    Arch Anat Histol Embryol; 1968; 51(1):299-311. PubMed ID: 4905271
    [No Abstract]   [Full Text] [Related]  

  • 46. [Studies on the effect of smoking on the urinary excretion of the metabolites of biogenic amines].
    Schmid E; Tautz NA; Winter P; Zicha L
    Verh Dtsch Ges Inn Med; 1965; 71():701-4. PubMed ID: 5877690
    [No Abstract]   [Full Text] [Related]  

  • 47. [Urinary elimination of 4-hydroxy-3-methoxymandelic acid in cardiac insufficiency].
    Valori C; Renzini V; Brunori CA; Corea L
    Atti Soc Ital Cardiol; 1968; 2():325-7. PubMed ID: 5743869
    [No Abstract]   [Full Text] [Related]  

  • 48. [Further investigations on adrenocortical function in schizophrenia and manic-depressive psychoses].
    ZELINSKII SP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1958; 58(1):46-54. PubMed ID: 13558681
    [No Abstract]   [Full Text] [Related]  

  • 49. [Serum and urine amino acid concentration in patients with functional psychoses of old age].
    Vorb'eva AD; Zubarev IuG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1971; 71(3):416-22. PubMed ID: 5569406
    [No Abstract]   [Full Text] [Related]  

  • 50. [Urinary excretion of 3-methoxy-4-hydroxymandelic acid in patients with virus hepatitis].
    Sodolski W; Stelmasiak T; Nadulska D; Gdula-Malec R
    Pol Arch Med Wewn; 1968; 41(2):281-6. PubMed ID: 5701449
    [No Abstract]   [Full Text] [Related]  

  • 51. Catecholamines and mania: the effect of alpha-methyl-para-tyrosine on manic behavior and catecholamine metabolism.
    Brodie HK; Murphy DL; Goodwin FK; Bunney WE
    Clin Pharmacol Ther; 1971; 12(2):218-24. PubMed ID: 5554938
    [No Abstract]   [Full Text] [Related]  

  • 52. A comparative study of axis I antecedents before age 18 of unipolar depression, bipolar disorder and schizophrenia.
    Rubino IA; Frank E; Croce Nanni R; Pozzi D; Lanza di Scalea T; Siracusano A
    Psychopathology; 2009; 42(5):325-32. PubMed ID: 19672135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Urinary excretion of 5-hydroxyindolacetic acid (5-HIAA) in 150 patients with depressive syndrome and maniacal agitation. (Its modifications by 5-hydroxy-tryptophan loading and therapy in the depressive states)].
    BURGERMEISTER JJ; DICK P; GARONNE G; GUGGISBERG M; TISSOT R
    Presse Med (1893); 1963 May; 71():1116-8. PubMed ID: 14016979
    [No Abstract]   [Full Text] [Related]  

  • 54. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
    Akiskal HS; Benazzi F; Perugi G; Rihmer Z
    J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Urinary elimination of catecholamine catabolites in physical exertion and after administration of catecholamines].
    Baciu I; Derevenco P; Rădulescu S; Sovrea I; Păsculescu G
    Fiziol Norm Patol; 1966; 12(5):421-8. PubMed ID: 5975701
    [No Abstract]   [Full Text] [Related]  

  • 56. Distinct seasonality of depressive episodes differentiates unipolar depressive patients with and without depressive mixed states.
    Sato T; Bottlender R; Sievers M; Möller HJ
    J Affect Disord; 2006 Jan; 90(1):1-5. PubMed ID: 16325920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Methodical and clinical studies on the excretion of 3-methoxy-4-hydroxymendelic acid in the urine].
    von STUDNITZ
    Scand J Clin Lab Invest; 1960; 12 Suppl 48():3-73. PubMed ID: 13835407
    [No Abstract]   [Full Text] [Related]  

  • 58. N-methylnicotinamide excretion and affective disorders.
    Cazzullo CL; Sacchetti E; Smeraldi E
    Psychol Med; 1976 May; 6(2):265-70. PubMed ID: 137411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary adenosine 3',5'-monophosphate excretion in affective disorders.
    Paul MI; Ditzion BR; Pauk GL; Janowsky DS
    Am J Psychiatry; 1970 Apr; 126(10):1493-7. PubMed ID: 4314024
    [No Abstract]   [Full Text] [Related]  

  • 60. Development and validation of the Affective Self Rating Scale for manic, depressive, and mixed affective states.
    Adler M; Liberg B; Andersson S; Isacsson G; Hetta J
    Nord J Psychiatry; 2008; 62(2):130-5. PubMed ID: 18569776
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.